All Stories

  1. High heart rate peaks from chest-strap recordings in athletes: Prevalence, characteristics, and clinical relevance
  2. Exercise blood pressure response does not differentiate endurance athletes with paroxysmal atrial fibrillation
  3. National Funding for Cardiac Arrest Research in Australia: An Analysis of Competitive Grant Schemes
  4. Electroanatomical Mapping May Identify Concealed Arrhythmogenic Cardiomyopathy in Endurance Athletes With Complex Ventricular Arrhythmias
  5. Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement
  6. Exercise blood pressure relative to fitness and cardiovascular outcomes: the EXERTION study
  7. Moving From Eyeball Assessment to Quantification of the Right Ventricular “Hot Spot” in Arrhythmogenic Cardiomyopathy
  8. Arrhythmias and structural remodeling in lifelong and retired master endurance athletes
  9. Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation
  10. “Letter to “Pathological contributors to organ damage and mortality in systemic sclerosis: A nationwide matched case-control study”: Author's Reply
  11. Maybe Valsalva, but please consider big hearts in middle-aged athletes as an explanation for atrial fibrillation prevalence
  12. Left atrioventricular ratio (LA:LV): using left ventricular size as the reference for identifying maladaptive left atrial remodelling
  13. Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease
  14. Diagnostic accuracy of different exercise blood pressure metrics in identifying hypertension on 24-h ambulatory blood pressure monitoring in athletes
  15. Balancing Exercise Benefits Against Heartbeat Consumption in Elite Cyclists
  16. Mechanistic Insights Into Reduced Arrhythmia Prevalence in Female Endurance Athletes
  17. Similar But Different
  18. Pathological contributors to organ damage and mortality in systemic sclerosis: a nationwide matched case-control study
  19. Trends and differences in the rates of autopsy in the United States, 2003 to 2020: A nationwide analysis
  20. The term ‘athlete’s heart’ encapsulates both male and female athletic hearts if indexed correctly
  21. Exercise in Inherited Cardiomyopathies: Optimizing the Dose-Response Curve
  22. Atrial fibrillation in former world-class rowers: role of environmental and genetic factors
  23. Validation of magnetic resonance imaging-derived venous oxygen saturation and oxygen consumption measurements during exercise
  24. Cardiac arrest in the Australian Alps: A 20-year analysis
  25. Female endurance athletes: smaller hearts but similar relationship between ventricular size, fitness and fibrosis as male athletes
  26. Recommendations for cardiac screening and emergency action planning in youth football: a FIFA consensus statement
  27. Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
  28. Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
  29. Cardiac arrest in Australia: a call to action
  30. Insights From a 20-Year Follow-Up of the First Heart Transplant Recipient to Complete an Ironman Triathlon
  31. Stepping up physical activity and fitness is needed for longevity
  32. Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities
  33. Location of Left Ventricular Outflow Tract Measurements for Stroke Volume Estimation With Echocardiography
  34. Genetics, Fitness, and Left Ventricular Remodelling: The Current State of Play
  35. Your Heart Can’t See What Sneakers You Are Wearing: Exercise Training Load in Endurance Athletes Is Inadequately Quantified in Sports Cardiology
  36. Editorial commentary: Exercise recommendations in hypertrophic cardiomyopathy shouldn't end at the recommendation
  37. Proposed minimum dataset for an athlete screening echocardiogram: the Standardised Transthoracic Echocardiogram Reporting in Athletes (STERA) protocol
  38. Preventing Allogeneic Stem Cell Transplant–Related Cardiovascular Dysfunction: ALLO-Active Trial
  39. RETRACTED AND REPLACED: Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease
  40. The role of multi-modality imaging for the assessment of left atrium and left atrial appendage: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA) of the European Socie...
  41. Coronary atherosclerosis in athletes: emerging concepts and preventive strategies
  42. Cardiac arrhythmia assessment with patch electrocardiogram versus insertable cardiac monitor: a cohort study in endurance athletes with atrial fibrillation
  43. Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction
  44. Left ventricular size and heart failure: A cardiac MRI assessment of 38,129 individuals from the UK Biobank
  45. Comparison of 6-lead smartphone ECG and 12-lead ECG in athletes and a genetic heart disease population
  46. Ventricular arrhythmias in association with athletic cardiac remodelling
  47. A Call to Action to Improve Cardiac Arrest Outcomes: A Report From the National Summit for Cardiac Arrest
  48. Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme
  49. Insights on blood pressure response to graded exercise in males and females across the age and fitness spectrum: reply
  50. Cardiorespiratory Fitness in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis
  51. 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play
  52. Diversity of ICD-10 coding for sudden arrhythmic death syndrome is likely to create a spurious rise in cases under new ICD-11 nomenclature
  53. Lifelong physiology of a former marathon world-record holder: the pros and cons of extreme cardiac remodeling
  54. Physiological Insights From Asymptomatic Severe Valvular Disease in a Highly Trained Athlete
  55. Rationale and Design of the Australasian Registry of Screening ECGs in National Athletes Project
  56. Blood pressure response to graded bicycle exercise in males and females across the age and fitness spectrum
  57. Cancer Therapy and Exercise Intolerance: The Heart Is But a Part
  58. Histological evaluation of cardiac remodelling in equine athletes
  59. The Oxygen Cascade According to HFpEF Likelihood
  60. International Criteria for Reporting Study Quality for Sudden Cardiac Arrest/Death Tool
  61. 2024 CSANZ Position Statement on Indications, Assessment and Monitoring of Structural and Valvular Heart Disease With Transthoracic Echocardiography in Adults
  62. Physiological determinants of decreased peak leg oxygen uptake in chronic disease: a systematic review and meta-analysis
  63. Prevalence of atrial septal defects and patent foramen ovale in a cohort of sudden cardiac death patients undergoing autopsy
  64. Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis
  65. Response to: Regard to assessing agreement between two raters with kappa statistics
  66. The aortic paradox: a nationwide analysis of 523 994 individual echocardiograms exploring fatal aortic dissection
  67. Outrunning the grim reaper: longevity of the first 200 sub-4 min mile male runners
  68. Characterizing the influence of cardiorespiratory fitness on left atrial size and function in the general population
  69. Integrating Cardio-Oncology Across the Research Pipeline, Policy, and Practice in Australia—An Australian Cardiovascular Alliance Perspective
  70. Reduced Ejection Fraction in Elite Endurance Athletes: Clinical and Genetic Overlap With Dilated Cardiomyopathy
  71. Sex disparities in bystander defibrillation for out-of-hospital cardiac arrest
  72. Toxicology Screening in Sports-Related Sudden Cardiac Death
  73. Determinants of Impaired Peak Oxygen Uptake in Breast Cancer Survivors: JACC: CardioOncology Primer
  74. Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis–Associated Interstitial Lung Disease
  75. The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre
  76. Lessons learnt in the first year of an Australian pediatric cardio oncology clinic
  77. Clinical outcomes of 10 years of cardiac screening in elite New Zealand athletes
  78. Prevalence of Multiple Causes of Death Within Young and Middle-Aged People Experiencing Sudden Cardiac Arrest
  79. Resuscitation of people with a do-not-resuscitate order: When does it happen and what are the outcomes?
  80. A Review on the Role of Exercise Training to Prevent a Decline in Cardiorespiratory Fitness and Cardiac Function in Breast Cancer Survivors
  81. Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation
  82. Effect of Exercise Training on Peak Aerobic Power After Heart Transplantation: A Brief Review
  83. Epidemiology of pediatric out-of-hospital cardiac arrest compared with adults
  84. Understanding Exercise Capacity: From Elite Athlete to HFpEF
  85. Ms-represented: strategies to increase female representation in sports cardiology research
  86. Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest in Australia: a narrative review
  87. A two-point strategy to clarify prognosis in >80 year olds experiencing out of hospital cardiac arrest
  88. Influence of exercise training on the left atrium: implications for atrial fibrillation, heart failure, and stroke
  89. Prevalence of illicit drug use in young patients with sudden cardiac death
  90. Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: A systematic review and meta-analysis
  91. Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease
  92. Associations between postrace atrial fibrillation and measures of performance, racing history and airway disease in horses
  93. Measurement of Stroke Volume With Echocardiography Compared to Gold Standard Cardiac Magnetic Resonance Imaging: An Observational Study
  94. Reply
  95. Semiautomatic Training Load Determination in Endurance Athletes
  96. The New South Wales Sudden Cardiac Arrest Registry: A Data Linkage Cohort Study
  97. Vascular Aging Is Accelerated in Hematological Cancer Survivors Who Undergo Allogeneic Stem Cell Transplant
  98. Sudden Cardiac Death in People With Schizophrenia
  99. Exercise-induced myocardial T1 increase and right ventricular dysfunction in recreational cyclists: a CMR study
  100. New-onset atrial fibrillation prediction: the HARMS2-AF risk score
  101. Return to play after myocarditis: time to abandon the one-size-fits-all approach?
  102. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction
  103. Too Little of a Good Thing
  104. Athlete's Heart: A Cardiovascular Step-By-Step Multimodality Approach
  105. No Association Between Out-of-Hospital Cardiac Arrest and COVID-19 Vaccination
  106. A systematic review of global autopsy rates in all-cause mortality and young sudden death
  107. Declining Recognition of Chest Pain as a Cardiac Symptom Should Act as a Shot in The Arm
  108. Effects of training adaption in endurance athletes with atrial fibrillation: protocol for a multicentre randomised controlled trial
  109. Lifelong endurance exercise and its relation with coronary atherosclerosis
  110. Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy
  111. Exercise-Induced Cardiac Remodeling and Atrial Fibrillation in Female Endurance Athletes
  112. Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study
  113. Reduced cardiovascular reserve capacity in long-term allogeneic stem cell transplant survivors
  114. Disease specific determinants of cardiopulmonary fitness in systemic sclerosis
  115. In a large primary care dataset, the CHA₂DS₂-VASc score leads to almost universal recommendation for anticoagulation treatment in those aged ≥65 years with atrial fibrillation
  116. Aerosol Generation During High Intensity Exercise—Implications for COVID-19 Transmission
  117. Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy
  118. Cardio-Oncology Recommendations for Pediatric Oncology Patients
  119. Late Afternoon Vigorous Exercise Increases Postmeal but Not Overnight Hypoglycemia in Adults with Type 1 Diabetes Managed with Automated Insulin Delivery
  120. Dynamic aspects of ventricular interaction during exercise in HFpEF and in pre‐capillary pulmonary hypertension
  121. Relating QRS voltages to left ventricular mass and body composition in elite endurance athletes
  122. The flatlining of cardiac arrest survival: can we revive the upward trend?
  123. The clinical implications of left ventricular diastolic dysfunction in systemic sclerosis
  124. Clinical and Pathologic Features of Out-of-Hospital Cardiac Arrest in Pregnancy
  125. Factors predicting cardiac arrest in acute coronary syndrome patients under 50: A state-wide angiographic and forensic evaluation of outcomes
  126. The Athlete’s Heart—Challenges and Controversies
  127. Type-2 Diabetes and the Clinical Importance of Exaggerated Exercise Blood Pressure
  128. Three-dimensional echocardiography of the athlete’s heart: a comparison with cardiac magnetic resonance imaging
  129. Inconsistent discharge diagnoses for young cardiac arrest episodes: insights from a statewide registry
  130. Analysis of athlete QT intervals by age: Fridericia and Hodges heart rate corrections outperform Bazett for athlete ECG screening
  131. Determinants of oxygen utilization in breast cancer: Similarities between heart failure with preserved ejection fraction
  132. Heart Failure With Preserved Ejection Fraction as an Exercise Deficiency Syndrome
  133. Obesity in young sudden cardiac death: Rates, clinical features, and insights into people with body mass index >50kg/m2
  134. Reduced death rates of elite Australian Rules footballers compared to age-matched general population
  135. Why Me? The Rise of Patients Without Traditional Cardiovascular Risk Factors
  136. Causes, circumstances, and potential preventability of cardiac arrest in the young: insights from a state-wide clinical and forensic registry
  137. Sudden cardiac death related to physical exercise in the young: a nationwide cohort study of Australia
  138. Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol
  139. Soldiers’ Heart: A Prospective Study of Cardiac Remodeling in Soldiers Undergoing Progressive Intensity Exercise Training
  140. Anabolic steroid misuse is an important reversible cause of cardiomyopathy: a case report
  141. Prevalence of Coronary Artery Anomalies in Young and Middle-Aged Sudden Cardiac Death Victims (from a Prospective State-Wide Registry)
  142. Return to exercise post-COVID-19 infection: A pragmatic approach in mid-2022
  143. Diastolic flow in the left ventricular outflow tract – A normal physiological and underappreciated echocardiographic finding
  144. Higher rates but similar causes of young out‐of‐hospital cardiac arrest in rural Australian patients
  145. The Impact of Ethnicity on Athlete ECG Interpretation: A Systematic Review
  146. On the characterization of athlete’s heart using 3D echocardiography
  147. Predictors and outcomes of in-hospital referrals for forensic investigation after young sudden cardiac death
  148. Risk Factors for Exercise-Associated Sudden Cardiac Death in Thoroughbred Racehorses
  149. Tackling an unmet need in sports cardiology: understanding exercise-induced cardiac remodelling and its clinical consequences
  150. Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis
  151. Arrhythmogenic Right Ventricular Cardiomyopathy
  152. Diverse stakeholder engagement at the heart of co-designing cardiac arrest care
  153. Fit, Female or Fifty–Is Cardiac Rehabilitation “Fit” for Purpose for All? A Systematic Review and Meta-Analysis With Meta-Regression
  154. Use of a smartphone electrocardiogram to diagnose arrhythmias during exercise in athletes: a case series
  155. Impaired biventricular contractile reserve in patients with diastolic dysfunction: insights from exercise stress echocardiography
  156. The dysfunctional right ventricle: the importance of multi-modality imaging
  157. Postmortem Interrogation of Cardiac Implantable Electronic Devices
  158. Rationale and design of the PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes
  159. A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy
  160. Myocardial fibrosis and arrhythmic burden in systemic sclerosis
  161. Intracoronary IgG4-related disease as an unusual cause of sudden cardiac arrest: a case series
  162. Arrhythmogenic Right Ventricular Cardiomyopathy With Right Ventricular Thrombus Found Incidentally on a Trauma CT Scan
  163. Disease Specific Determinants of Cardiopulmonary Fitness in Systemic Sclerosis
  164. Response by Howden et al to Letter Regarding Article, “Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension”
  165. Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study
  166. A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes
  167. Athletes with mild COVID-19 illness demonstrate subtle imaging abnormalities without exercise impairment or arrhythmias
  168. Cardiorespiratory Fitness, Workload, and the Blood Pressure Response to Exercise Testing
  169. Multiday cycles of heart rate are associated with seizure likelihood: An observational cohort study
  170. Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management
  171. Right ventricular and cyclic guanosine monophosphate signalling abnormalities in stages B and C of heart failure with preserved ejection fraction
  172. First Randomized Controlled Trial of Hybrid Closed Loop Versus Multiple Daily Injections or Insulin Pump Using Self-Monitoring of Blood Glucose in Free-Living Adults with Type 1 Diabetes Undertaking Exercise
  173. Prevention of Pathological Atrial Remodeling and Atrial Fibrillation
  174. The economic impact of sudden cardiac arrest
  175. Exercise oscillatory ventilation during autonomic blockade in young athletes and healthy controls
  176. Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension
  177. Comparison between a 6‑lead smartphone ECG and 12‑lead ECG in athletes
  178. The End Unexplained Cardiac Death (EndUCD) Registry for Young Australian Sudden Cardiac Arrest
  179. Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET)
  180. Athletes with valvular heart disease and competitive sports: a position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology
  181. Endurance exercise and the risk of cardiovascular pathology in men: a comparison between lifelong and late-onset endurance training and a non-athletic lifestyle - rationale and design of the Master@Heart study, a prospective cohort trial
  182. Response to Sanchis-Gomar et al. ‘Atrial fibrillation in athletes and non-athletes: evidence of different causative mechanisms’
  183. Optimal Detection of Cardiac Sequelae
  184. The effect of posture on maximal oxygen uptake in active healthy individuals
  185. Prescribing Exercise in Early-Stage Breast Cancer During Chemotherapy: A Simple Periodized Approach to Align With the Cyclic Phases of Chemotherapy
  186. Traditional markers of cardiac toxicity fail to detect marked reductions in cardiorespiratory fitness among cancer patients undergoing anti-cancer treatment
  187. The Australia and New Zealand Cardio‐Oncology Registry: evaluation of chemotherapy‐related cardiotoxicity in a national cohort of paediatric cancer patients
  188. Exercise-Induced Arrhythmogenic (Right Ventricular) Cardiomyopathy Is Real…if you Consider it
  189. Predicting Left Ventricular Mass Using ECG, Demographic and DXA Features
  190. Acute glycaemic management before, during and after exercise for cardiac rehabilitation participants with diabetes mellitus: a joint statement of the British and Canadian Associations of Cardiovascular Prevention and Rehabilitation, the International C...
  191. Proof that exercise works, now it’s time for optimizing delivery to our patients with pulmonary hypertension
  192. Is the healthy respiratory system built just right, overbuilt, or underbuilt to meet the demands imposed by exercise?
  193. Mind the gap: Knowledge deficits in evaluating young sudden cardiac death
  194. Persistent Troponin Elevation in Left-Dominant Arrhythmogenic Cardiomyopathy
  195. Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19
  196. Multiday cycles of heart rate are associated with seizure likelihood
  197. Can post-mortem coronary artery calcium scores aid diagnosis in young sudden death?
  198. Smoke but no fire: increased myocardial infarction with normal coronary arteries in the Australian bushfires?
  199. Reassuring News for Athletes With Atrial Fibrillation, But Perhaps Not All Athletes
  200. Measuring atrial stasis during sinus rhythm in patients with paroxysmal atrial fibrillation using 4 Dimensional flow imaging
  201. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
  202. The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis
  203. Differing mechanisms of atrial fibrillation in athletes and non-athletes: alterations in atrial structure and function
  204. Helping patients to help themselves: informing individuals predisposed to arrhythmogenic cardiomyopathy
  205. Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol
  206. Prospective long-term follow-up analysis of the cardiovascular system in marathon runners: study design of the Pro-MagIC study
  207. Audit of a cardiac screening policy for elite Australian cricketers
  208. Left Ventricular Fibrosis in Middle-Age Athletes and Physically Active Adults
  209. Left ventricular remodeling in elite and sub‐elite road cyclists
  210. Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy
  211. Reduced Exercise Capacity in Diabetes Mellitus Is Not Associated with Impaired Deformation or Twist
  212. The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview
  213. Cardiac screening of athletes: consensus needed for clinicians on indications for follow-up echocardiography testing
  214. Cardiovascular Screening of Elite Athletes by Sporting Organizations in Australia: A Survey of Chief Medical Officers
  215. Fears of a Big Bang for Rugby Players, Urgent Validation Required
  216. Association between physical activity and risk of incident arrhythmias in 402 406 individuals: evidence from the UK Biobank cohort
  217. Multiday Cycles of Heart Rate Modulate Seizure Likelihood at Daily, Weekly and Monthly Timescales: An Observational Cohort Study
  218. Exercise cardiovascular magnetic resonance: development, current utility and future applications
  219. Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness
  220. Cardiac arrest and sudden cardiac death registries: a systematic review of global coverage
  221. The Cardiac Society of Australia and New Zealand Position Statement on the Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy (2019 Update)
  222. Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study
  223. Echocardiographic Assessment of Left Ventricular Remodeling in American Style Footballers
  224. Exercise Attenuates Cardiotoxicity of Anthracycline Chemotherapy Measured by Global Longitudinal Strain
  225. Right Ventricular Function
  226. Evaluation of Cardiac Function in Women With a History of Preeclampsia: A Systematic Review and Meta‐Analysis
  227. Pulmonary vascular remodelling in athletes: an anti-concept to be proved
  228. Atrial fibrillation in athletes: different but the same?
  229. Right ventricular strain rate during exercise accurately identifies male athletes with right ventricular arrhythmias
  230. ECG-based cardiac screening programs: Legal, ethical, and logistical considerations
  231. Brief recommendations for participation in leisure time or competitive sports in athletes–patients with coronary artery disease: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  232. Impaired Cardiac Reserve and Abnormal Vascular Load Limit Exercise Capacity in Chronic Thromboembolic Disease
  233. Sildenafil enhances central hemodynamic responses to exercise, but not V̇o2peak, in people with diabetes mellitus
  234. Brief recommendations for participation in competitive sports of athletes with arterial hypertension: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  235. Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association
  236. Heart Rate Reserve in Fontan Patients: Chronotropic Incompetence or Hemodynamic Limitation?
  237. Unsupervised respiratory signal extraction from ungated cardiac magnetic resonance imaging at rest and during exercise
  238. Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer Chemotherapy
  239. Relation of Alcohol Consumption to Left Ventricular Fibrosis Using Cardiac Magnetic Resonance Imaging
  240. Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary Fibrosis
  241. Pulmonary Hypertension
  242. Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy
  243. Sudden Death and Ventricular Arrhythmias in Athletes: Screening, De-Training and the Role of Catheter Ablation
  244. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  245. Electrocardiographic Features Differentiating Arrhythmogenic Right Ventricular Cardiomyopathy From an Athlete’s Heart
  246. Measurement of microvascular function in patients presenting with thrombolysis for ST elevation myocardial infarction, and PCI for non-ST elevation myocardial infarction
  247. Regular Alcohol Consumption Is Associated With Impaired Atrial Mechanical Function in the Atrial Fibrillation Population
  248. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients
  249. Misclassification of cricket in the American College of Cardiology (ACC) Task Force classification of sports
  250. Advanced Imaging to Phenotype Patients With a Systemic Right Ventricle
  251. Acute metabolic and cardiovascular effects of mirabegron in healthy individuals
  252. Drugs in Sport — A Change is Needed, but What?
  253. Sports Cardiology – A Bona Fide Sub-Specialty
  254. Sports Cardiology – Example Illustrative Cases
  255. Athlete’s Heart: Is the Morganroth Hypothesis Obsolete?
  256. Standing up to the cardiometabolic consequences of hematological cancers
  257. What May the Future Hold for Sports Cardiology?
  258. Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC)
  259. Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes
  260. Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy
  261. Recommendations for participation in leisure time or competitive sports in athletes-patients with coronary artery disease: a position statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  262. Right Heart-Pulmonary Circulation Unit in Cardiomyopathies and Storage Diseases
  263. The Right Heart International Network (RIGHT-NET)
  264. The ventricular residence time distribution derived from 4D flow particle tracing: a novel marker of myocardial dysfunction
  265. Atrial remodeling and ectopic burden in recreational athletes: Implications for risk of atrial fibrillation
  266. Exercise cardiac magnetic resonance to differentiate athlete’s heart from structural heart disease
  267. Exercise Blood Pressure Guidelines: Time to Re-evaluate What is Normal and Exaggerated?
  268. Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study
  269. Diagnosis and Significance of Pulmonary Microvascular Disease in Diabetes
  270. Mechanisms of the Improvement in Peak VO 2 With Exercise Training in Heart Failure With Reduced or Preserved Ejection Fraction
  271. The Right Ventricle: From Bench to Bedside
  272. Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans
  273. New International Guidelines for the Interpretation of the Electrocardiograph in Athletes: a “Traffic Light” Tool for Maximising Diagnostic Specificity
  274. Atrial deformation in athletes with AF: chronic adverse remodelling or transient mechanical stunning?
  275. Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans
  276. Blood Pressure Response to Exercise and Cardiovascular Disease
  277. Chemotherapy-related cardiotoxicity: are Australian practitioners missing the point?
  278. A focus on the greatness of the lesser circulation - Spotlight Issue on the Right Ventricle
  279. State of the Art Review: Atrial Fibrillation in Athletes
  280. Point:Counterpoint
  281. Exercise and the right ventricle: a potential Achilles’ Heel
  282. Safety Concerns regarding article: Reliability and Validity of a Self-paced Cardiopulmonary Exercise Test in Post-MI Patients. L. A. Jenkins, A. Mauger, J. Fisher, J. Hopker. Int J Sports Med 2017; 38: 300–306.
  283. SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T
  284. Closed-Loop Insulin Delivery for Adults with Type 1 Diabetes Undertaking High-Intensity Interval Exercise Versus Moderate-Intensity Exercise: A Randomized, Crossover Study
  285. Pulmonary Vascular Function During Exercise
  286. International criteria for electrocardiographic interpretation in athletes: Consensus statement
  287. International recommendations for electrocardiographic interpretation in athletes
  288. International Recommendations for Electrocardiographic Interpretation in Athletes
  289. Right ventricular and pulmonary vascular reserve in asymptomatic BMPR2 mutation carriers
  290. Cardiovascular Effects of Performance-Enhancing Drugs
  291. Right ventricular dilatation and function
  292. Increased Flow, Dam Walls, and Upstream Pressure
  293. Atrial volume and function during exercise in health and disease
  294. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
  295. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
  296. Pathophysiology of exercise intolerance in breast cancer survivors with preserved left ventricular ejection fraction
  297. Sports Cardiology
  298. A Modern Definition of the Athlete’s Heart—for Research and the Clinic
  299. Sports Cardiology: Comprehensive Clinical Care for Athletes and Highly Active Individuals
  300. Idiopathic Ventricular Tachycardia/Ventricular Fibrillation
  301. Letter by Heidbuchel et al Regarding Article, “Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study”
  302. Stressing the right ventricular-pulmonary vascular unit: beyond pulmonary vascular resistance
  303. Effect of Experience and Training on the Concordance and Precision of Strain Measurements
  304. Acute effect of static exercise in patients with aortic regurgitation assessed by cardiovascular magnetic resonance: role of left ventricular remodelling
  305. Exercise-induced cardiac fatigue: the need for speed
  306. Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study
  307. Accuracy of Echocardiography to Evaluate Pulmonary Vascular and RV Function During Exercise
  308. The Potential Cardiotoxic Effects of Exercise
  309. review of the current status of experimental models for Systems Biology research
  310. Exercise-induced pulmonary oedema in endurance triathletes
  311. Let's keep running… exercise, basic science and the knowledge gaps
  312. Effect of respiration on cardiac filling at rest and during exercise in Fontan patients: A clinical and computational modeling study
  313. Understanding the Mechanism of T-Wave Inversion in Athletes May Be Key to Best Management
  314. T-wave subtleties in screened athletes: sharpening the lead or whittling the pencil away?
  315. Reply to Sanchis-Gomar et al.—Undeniable Benefits of Exercise Should Not Preclude Inquiry Into the Mechanisms of Arrhythmias in Athletes
  316. Young Women With Abdominal Obesity Have Subclinical Myocardial Dysfunction
  317. Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie?
  318. Early repolarization patterns associated with increased arrhythmic risk are common in young non-Caucasian Australian males and not influenced by athletic status
  319. Relationship between Inflammatory Cytokines and Indices of Cardiac Dysfunction following Intense Endurance Exercise
  320. Response to Letters Regarding Article, “Can Intensive Exercise Harm the Heart? You Can Get Too Much of a Good Thing”
  321. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes
  322. Abnormal right ventricular relaxation in pulmonary hypertension
  323. Correction
  324. Right ventricular suction: an important determinant of cardiac performance
  325. Signs of RV overload on the athlete’s ECG
  326. Let's keep running… exercise, basic science and the knowledge gaps
  327. Physiologic and pathophysiologic changes in the right heart in highly trained athletes
  328. Is Exercise Good for the Right Ventricle? Concepts for Health and Disease
  329. Pulmonary Vascular and Right Ventricular Reserve in Patients With Normalized Resting Hemodynamics After Pulmonary Endarterectomy
  330. Right Precordial T-Wave Inversion in Healthy Endurance Athletes Can Be Explained by Lateral Displacement of the Cardiac Apex
  331. Exercise pathophysiology and sildenafil effects in chronic thromboembolic pulmonary hypertension
  332. Straining the RV to Predict the Future∗
  333. Acute effect of static exercise on the cardiovascular system: assessment by cardiovascular magnetic resonance
  334. Modest agreement in ECG interpretation limits the application of ECG screening in young athletes
  335. Defining the interaction between exercise and arrhythmogenic right ventricular cardiomyopathy
  336. Author response
  337. Exercise and Cardiovascular Risk in Patients With Hypertension
  338. The right ventricle following prolonged endurance exercise: are we overlooking the more important side of the heart? A meta-analysis
  339. Exercise blood pressure: clinical relevance and correct measurement
  340. Fluoroscopic Ring of Pannus within a Mechanic Mitral Valve: A Novel Sign of Calcified Pannus Infiltration
  341. Right Heart Structural and Functional Remodeling in Athletes
  342. Can Intensive Exercise Harm the Heart?: You Can Get Too Much of a Good Thing
  343. Can Intensive Exercise Harm the Heart?: The Benefits of Competitive Endurance Training for Cardiovascular Structure and Function
  344. The response of the pulmonary circulation and right ventricle to exercise: exercise-induced right ventricular dysfunction and structural remodeling in endurance athletes (2013 Grover Conference series)
  345. Right Ventricular Fatigue Developing during Endurance Exercise
  346. Comparison of Frequency of Significant Electrocardiographic Abnormalities in Endurance Versus Nonendurance Athletes
  347. Sildenafil Improves Exercise Hemodynamics in Fontan Patients
  348. Interaction between respiration and right versus left ventricular volumes at rest and during exercise: a real-time cardiac magnetic resonance study
  349. Right Ventricular Structure and Function During Exercise
  350. The Impact of Long-Term Endurance Sports on the Right Ventricle: Evidence for Exercise-Induced Arrhythmogenic RV Cardiomyopathy
  351. Transit of micro-bubbles through the pulmonary circulation of Thoroughbred horses during exercise
  352. Cardiac Imaging and Stress Testing Asymptomatic Athletes to Identify Those at Risk of Sudden Cardiac Death
  353. Atrial fibrillation in athletes and the interplay between exercise and health
  354. To assess exertional breathlessness you must exert the breathless
  355. Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
  356. The Seattle Criteria increase the specificity of preparticipation ECG screening among elite athletes
  357. Response to Letter Regarding Article, "Cardiac Magnetic Resonance Imaging: A New Gold Standard for Ventricular Volume Quantification During High-Intensity Exercise"
  358. Reduced Right Ventricular Myocardial Strain in the Elite Athlete May Not Be a Consequence of Myocardial Damage.“Cream Masquerades as Skimmed Milk”
  359. Exercise-Induced Arrhythmogenic Right Ventricular Cardiomyopathy
  360. Can Intense Endurance Exercise Cause Myocardial Damage and Fibrosis?
  361. Cardiac MRI: A New Gold Standard for Ventricular Volume Quantification During High-Intensity Exercise
  362. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence?
  363. Targeted therapies in breast cancer: are heart and vessels also being targeted?
  364. The right heart in athletes
  365. The right heart in athletes
  366. The athlete's heart
  367. Exercise Strain Rate Imaging Demonstrates Normal Right Ventricular Contractile Reserve and Clarifies Ambiguous Resting Measures in Endurance Athletes
  368. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes
  369. Asymmetric collimation can significantly reduce patient radiation dose during pulmonary vein isolation†
  370. Should Pre-participation Cardiovascular Screening for Competitive Athletes be Introduced in Australia? A Timely Debate in a Sport-loving Nation
  371. Maximal oxygen consumption is best predicted by measures of cardiac size rather than function in healthy adults
  372. CardioPulse Articles
  373. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation
  374. Disproportionate Exercise Load and Remodeling of the Athlete's Right Ventricle
  375. Long-term endurance sport is a risk factor for development of lone atrial flutter
  376. Pulmonary Vascular Resistance as Assessed by Bicycle Stress Echocardiography in Patients With Atrial Septal Defect Type Secundum
  377. Strenuous endurance exercise: is more better for everyone? Our genes won't tell us
  378. Clinical Consequences of Intense Endurance Exercise Must Include Assessment of the Right Ventricle
  379. Right ventricular function by strain echocardiography
  380. One- and Two-dimensional Estimation of Right and Left Ventricular Size and Function—Comparison with Cardiac Magnetic Resonance Imaging Volumetric Analysis
  381. Pulmonary transit of agitated contrast is associated with enhanced pulmonary vascular reserve and right ventricular function during exercise
  382. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin
  383. Continuing Medical Education Program inEchocardiography
  384. Left Ventricular Torsion Parameters are Affected by Acute Changes in Load
  385. The echocardiographic assessment of the right ventricle: what to do in 2010?
  386. Left ventricular strain and strain rate: characterization of the effect of load in human subjects
  387. Three-dimensional cardiac rotational angiography: effective radiation dose and image quality implications
  388. The Fontan circulation: who controls cardiac output?
  389. Left Ventricular Untwisting Is an Important Determinant of Early Diastolic Function
  390. Athlete's Heart: The Potential for Multimodality Imaging to Address the Critical Remaining Questions
  391. Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonist
  392. Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise
  393. Augmentation of Left Ventricular Torsion with Exercise is Attenuated with Age
  394. Reduced and delayed untwisting of the left ventricle in patients with hypertension and left ventricular hypertrophy: a study using two-dimensional speckle tracking imaging
  395. Effect of Heart Rate on Tissue Doppler Measures of Diastolic Function
  396. Exercise—Is it Possible to Have Too Much of a Good Thing?
  397. No Evidence of Sustained Myocardial Injury Following an Ironman Distance Triathlon